-
Editor's Letter
Shoot for the MoonHow can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Get Involved
The Gift of a GetawayGive patients and their families a break from cancer.
by Maria Wolf
-
Global Report
A Dutch DilemmaWhile much of the Western world was tightening restrictions on smoking, one European nation, the Netherlands, found itself embroiled in a political struggle between individual freedoms and public health.
by Cynthia Ryan
-
Get Involved
A Family’s TributeCindy's Legacy provides financial support to families who are affected by cancer.
by Eileen Glanton Loftus
-
Editor's Letter
Making Progress in Treating CancerCancer Today's Winter 2015/2016 issue describes advances in lung cancer, big data and more.
by Kevin McLaughlin
-
Forward Look
Should the Age to Buy Cigarettes Be 21?Q&A with CDC's Brian King on reducing teen access to tobacco products.
by Chris Palmer
-
Q&A
Conversation StarterCancer survivor Emily McDowell creates greeting cards that give people the words to talk about a difficult disease.
by Stephen Ornes
-
Editor's Letter
Cancer Research Needs Robust Federal FundingNow's the time to show support for medical research funding.
by Kevin McLaughlin
-
Survivor Profile
Stop the SilenceCancer survivor Cherry Sloan-Medrano works to encourage a conversation about cancer among Asians in the U.S.
by Jenny Song
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
